
The streets of Denmark have been paved with gold for biotech companies over the past few years, and a number of firms have gained historically large amounts from investors.
This can be felt at life science incubator Bioinnovation Institute (BII), which has recently surpassed a milestone that, according to CEO Jens Nielsen, demonstrates that the life science ecosystem is "on top form."
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app